Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Different Doses of Roxadustat Treatment on Hemoglobin Target-met in Peritoneal Dialysis Patients

NCT04454879 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT04454879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04454879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Different Doses of Roxadustat Treatment on Hemoglobin Target-met in Peritoneal Dialysis Patients
Lead sponsor
Peking University First Hospital
Phase
Phase 4
Overall status
Completed
Start date
July 1, 2020
Completion date
August 3, 2021
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal anemia